Các bài báo quốc tế, Tin tức

CÔNG BỐ QUỐC TẾ NĂM HỌC 2024-2025

Posted on by Huepharm

CÔNG BỐ QUỐC TẾ NĂM HỌC 2024-2025

KHOA DƯỢC

  1. Nguyen T.K., Thi Pham K.H., Trung T.T., et al. (2025). Alpha-glucosidase inhibitory activities of furanoflavonoids isolated from Pongamia pinnata: DFT calculation, molecular modelling and in vitro studies. Natural Product Communications, 20(2), 1934578X251321051.
  2. Hoang T.H.X., Tran T.-H., Doan T.Q., et al. Chemical Composition, Anti-Inflammatory Effect, and Molecular Docking of Essential Oils Extracted From Illigera celebica Hance. (Hernandiaceae). Chemistry & Biodiversity, e01063.
  3. Le N.T., Nguyen H.V., Le G.Q., et al. (2025). Eco-friendly extraction and recovery of triterpenoids from persimmon leaves (Diospyros kaki L.f.) using ultrasound-assisted deep eutectic solvents and macroporous resins. Anal Methods, 17(7), 1567–1578.
  4. Doan T.Q., Nguyen H.T., Hoang T.H.X., et al. (2025). Chemical composition and biological activities of essential oil from Illigera rhodantha Hance. (Hernandiaceae) from Vietnam. Journal of Essential Oil Bearing Plants, 28(2), 331–339.
  5. Hoang T., Le Q., Nguyen H., et al. (2024). In vivo anti-acetylcholinesterase, antioxidant activities and acute toxicity of the alkaloid fraction from Hippeastrum reticulatum. The Thai Journal of Pharmaceutical Sciences, 48(3).
  6. Doan N.A.T., Hoang H.N.T., Tuan Le A., et al. (2025). Anti-inflammatory and anti-proliferative activities of secondary metabolites isolated from the leaves of Gymnosporia chevalieri. Nat Prod Res, 1–10.
  7. Nguyen H.V., Nguyen H.T.T., Le N.T., et al. (2025). Triterpenoid From Persimmon Leaves (Diospyros kaki L.f.) Exerted Anti-Type 2 Diabetic Effects and No Toxicity in Experimental Animals. Basic Clin Pharmacol Toxicol, 137(2), e70081.
  8. Nguyen K.V., Nguyen L.K.T., Le N.T., et al. (2025). Sustainable Extraction of the Tetrahydropalmatine Alkaloid from Stephania rotunda Lour. Tubers Using Eco-Friendly Solvent Systems. ACS Omega, 10(35), 40313–40323.
  9. Nguyen K.V., Le N.T., Dang V.T.T., et al. (2025). Alkaloid Extraction from Coptis chinensis Franch. Using Ultrasound-Assisted Aqueous Solutions of Surfactants, Organic Acids, Deep Eutectic Solvents, and Supramolecular Deep Eutectic Solvents. Molecules, 30(7), 1418.
  10. Le N.T., Le T.T., Ho D.V., et al. (2024). Extraction and recovery of bioactive alkaloids from Phellodendron amurense Rupr. Using ultrasound-assisted green solvents and macroporous resins. Sustainable Chemistry and Pharmacy, 42, 101809.
  11. Le N.T., Nguyen L.T., Thi Nguyen N.A., et al. (2025). Unlocking the potential of bio-based solvents for sustainable triterpenoid extraction: a case study on betulinic acid from Tetracera scandens (L.) Merr. Separation and Purification Technology, 370, 133196.
  12. Heinämäki J., Koshovyi O., Botsula I., et al. (2025). Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives. J Tissue Eng Regen Med, 2025, 2812191.
  13. Khanh Nguyen L.T., Thi Le H.B., Van Anh Tran T., et al. (2025). Inhibition of pro-inflammatory cytokines by homalolide A and homalomenol A isolated from rhizomes of Homalomena pendula. Z Naturforsch C J Biosci, 80(7–8), 353–359.
  14. Hoang H.N.T., Huu Dat T.T., VietCuong L.C., et al. (2025). A new 14-membered cembrane-type diterpenoid and other constituents from the aerial parts of Jatropha integerrima Jacq. and their antibacterial activity. Nat Prod Res, 1–7.
  15. Nguyen T.T.T., Tran V.A., Tran T.H., et al. Megastigmanes isolated from Boehmeria nivea leaves and their immunomodulatory effect on IL-1β and IL-10 production in RAW264.7 macrophages. RSC Adv, 15(15), 11549–11561.
  16. Hai N.T.T., Bui T.Q., My T.T.A., et al. (2025). On the antifungal potentials of Piper betle L. ethanol extract against sclerotium rolfsii for pesticidal applicability: In vitro evidence and in silico screening. Results in Chemistry, 16, 102477.
  17. Pham T.V., Thanh L.L., Le H.T., et al. (2025). Composition and Bioactivities of n-Hexane Extract from Jatropha integerrima Aerial Parts in Vietnam. HUJPHARM, 45(3), 200–210.
  18. Minh D.T.C., Nhu N.T.Q., Thi L.A., et al. (2025). Comparison of excitation wavelengths in surface-enhanced Raman spectroscopy coupled to thin-layer chromatography for tadalafil and vardenafil detection as adulterants in herbal healthcare products. Anal Methods, 17(14), 2867–2877.
  19. Phan D.T.A., Kongkaew C., Heinrich M., et al. (2025). From “traditional” remedies to “modern” supplements: a systematic review and meta-analysis of pharmaceutical adulteration in weight-loss natural products. Front Pharmacol, 16, 1594975.
  20. Minh D.T.C., Thi L.A., May N.T., et al. (2025). Efficient On-Site Detection of Simultaneous Adulteration of Paracetamol and Chlorpheniramine in Herbal Products Using Thin-Layer Chromatography Coupled to Dynamic Surface-Enhanced Raman Spectroscopy. SEPARATION SCIENCE PLUS, 8(5), e70064.
  21. Chung H.V., Phong N.H., Minh D.T.C., et al. (2025). Electrochemical determination of paracetamol and chlorpheniramine using AuNPs-rGO modified glassy carbon electrode: Original scientific paper. Journal of Electrochemical Science and Engineering, 2841–2841.
  22. Le T.T.N., Le T.T.H., Le H.H., et al. (2024). Preparation, Physicochemical, and Antibacterial Characterization of Nanostructured Lipid Carrier System Containing Tinidazole for Buccal Mucosa Delivery. BioNanoSci, 15(1), 99.
  23. Tran T.-H., Nguyen T.-M.-H., Cao T.-C.-N., et al. (2025). Integrating synthesis, enzyme inhibition and in silico studies: Carbamoyl luteolin derivatives targeting Alzheimer’s disease. Journal of the Chinese Chemical Society, 72(6), 739–750.
  24. Tran T.-H., Tran T.-S., Nguyen M.-H., et al. (2025). Carbamoyl flavonoids as dual inhibitors of acetylcholinesterase and monoacylglycerol lipase: synthesis, in vitro evaluation, and computational studies. Med Chem Res, 34(7), 1544–1556.
  25. Tran T.-H., Doan D.-N.-H., Cao T.-C.-N., et al. Flavonoid carbamate hybrids: design, synthesis, and evaluation as multi-target enzyme inhibitors for Alzheimer’s disease. RSC Adv, 15(21), 16855–16868.
  26. Luu T.N.N., Ngo H.T.T., Ho X.D., et al. (2025). Direct medical cost of adjuvant systemic treatment for HER2-positive breast cancer in Vietnam. J Pharm Pharmacogn Res, 13(1), 264–273.
  27. Nguyen T.T.P., Ngo T.K.C., Le T.T.A., et al. (2025). Psychometric properties of the Vietnamese version of the Copenhagen Burnout Inventory (CBI-V) and its associated factors among community pharmacists in Thua Thien Hue, Vietnam. J Health Psychol, 30(7), 1577–1592.
  28. Nguyen C.V., Nguyen H.T.T., Luu Nguyen T.N., et al. (2025). Health-Related Quality of Life of Non-Small Cell Lung Cancer Patients Treated with Targeted Therapy: Based on the EQ-5D-5L Scale in Vietnam. Asian Pac J Cancer Prev, 26(4), 1277–1283.
  29. Nguyen P.V., Tran T.T.T., Nguyen H.T.T., et al. (2025). Motivation, barriers, and willingness to participate in clinical trials for novel cancer treatments among the Vietnamese population. PLOS ONE, 20(8), e0331250.

 

 

Xem thêm: